AngioDynamics, Inc. (ANGO) recently announced that it has entered into a settlement agreement with Becton, Dickinson and Company (BDX) , popularly known as BD, to resolve all outstanding patent litigation with C.R. Bard, Inc., an affiliate of BD. AngioDynamics is likely to benefit from the settlement of this prolonged legal dispute to a successful resolution as it will lower the company’s ongoing legal expenses and terminate more than 10-year distraction. Price Performance For the past six months, ANGO’s sh ...